Revolutionizing Sleep Apnea Treatment Through Biological Innovation

Apneacure is developing a category-defining solution for Obstructive Sleep Apnea (OSA)—a global health crisis affecting 1 billion people worldwide. Our breakthrough Biological Tendon Tether Technology (BTTT) offers the world's first permanent, biological solution that addresses the root cause of airway collapse.

The Challenge We're Solving
450 million OSA patients worldwide require intervention, yet current treatments fail to deliver lasting results. CPAP devices face 30-60% non-adherence rates, and the condition costs the EU alone €184 billion annually. Patients need a permanent solution—not lifelong dependence on mechanical devices.

Our Innovation
BTTT represents a paradigm shift in OSA treatment:

→ One-time surgical implantation with permanent anatomical correction
→ Biological scaffold that naturally integrates and grows tendon-like tissue
→ Passive system requiring no external intervention
→ Scaffold completely dissolves after 8 months as the body heals itself

Clinical trials are underway with rigorous safety monitoring, following successful animal trials and first-in-human implantation milestones.

Apneacure

Org chart

Teams

Offices